Liraglutide for weight loss in obese people - Authors' reply

The Lancet

Volumn 375, Issue 9714, 2010, Pages 552-553

  Astrup, Arne ^a   Rössner, Stephan ^a   Van Gaal, Luc ^a   Rasmusen, Mads F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR; LIRAGLUTIDE; PLACEBO;

CALORIC INTAKE; DOSE RESPONSE; HUMAN; LETTER; NAUSEA AND VOMITING; OBESITY; POST HOC ANALYSIS; PRIORITY JOURNAL; SATIETY; STOMACH EMPTYING; WEIGHT REDUCTION;

EID: 76249125639     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60227-9     Document Type: Letter

References (2)

1. Verdich C., Flint A., Gutzwiller J.-P., et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86 (2001) 4382-4389
2. Madsbad S. Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)-preclinical and clinical results. Best Pract Res Clin Endocrinol Metab 23 (2009) 463-477